Closing of Underwritten Registered Direct Offering of Common Stock

Financial

Josh SandbergJanuary 29, 2018
1,296

Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

WALTHAM, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell…
Read More »